Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics.

Kjekshus J, Dunselman P, Blideskog M, Eskilson C, Hjalmarson A, McMurray JV, Waagstein F, Wedel H, Wessman P, Wikstrand J; CORONA Study Group.

Eur J Heart Fail. 2005 Oct;7(6):1059-69.

PMID:
16227145
[PubMed - indexed for MEDLINE]
2.

Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.

Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Davidson MH.

Clin Ther. 2007 Nov;29(11):2385-94.

PMID:
18158079
[PubMed - indexed for MEDLINE]
3.

Effects of once weekly rosuvastatin among patients with a prior statin intolerance.

Backes JM, Moriarty PM, Ruisinger JF, Gibson CA.

Am J Cardiol. 2007 Aug 1;100(3):554-5. Epub 2007 Jun 18.

PMID:
17659946
[PubMed - indexed for MEDLINE]
4.

[Treatment of chronic heart failure. The time of statins?].

Mareev VIu.

Kardiologiia. 2005;45(12):4-10. Review. Russian. No abstract available.

PMID:
16353040
[PubMed - indexed for MEDLINE]
5.

[No reason to start treatment with statins in patients with moderate to severe heart failure].

Stalenhoef AF.

Ned Tijdschr Geneeskd. 2008 Mar 1;152(9):486-8. Dutch.

PMID:
18389878
[PubMed - indexed for MEDLINE]
6.

Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study.

Ashton E, Windebank E, Skiba M, Reid C, Schneider H, Rosenfeldt F, Tonkin A, Krum H.

Int J Cardiol. 2011 Feb 3;146(3):404-7. doi: 10.1016/j.ijcard.2009.12.028. Epub 2010 Jan 20.

PMID:
20085851
[PubMed - indexed for MEDLINE]
7.

Statin treatment for patients with heart failure.

Tang WH, Francis GS.

Nat Rev Cardiol. 2010 May;7(5):249-55. doi: 10.1038/nrcardio.2010.29. Epub 2010 Mar 16. Review.

PMID:
20234351
[PubMed - indexed for MEDLINE]
8.

Efficacy and safety of rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: results of the POLARIS study.

Leiter LA, Rosenson RS, Stein E, Reckless JP, Schulte KL, Schleman M, Miller P, Palmer M, Sosef F; POLARIS study investigators.

Atherosclerosis. 2007 Oct;194(2):e154-64. Epub 2007 Jan 16.

PMID:
17229426
[PubMed - indexed for MEDLINE]
9.

[The CORONA study].

Metra M, Zacá V, Nodari S, Cas LD, Maggioni AP.

G Ital Cardiol (Rome). 2008 Apr;9(4):229-33. Italian. No abstract available.

PMID:
18543792
[PubMed - indexed for MEDLINE]
10.

Efficacy of rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins.

Gadarla M, Kearns AK, Thompson PD.

Am J Cardiol. 2008 Jun 15;101(12):1747-8. doi: 10.1016/j.amjcard.2008.02.061. Epub 2008 Apr 11.

PMID:
18549851
[PubMed - indexed for MEDLINE]
11.

Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure).

McMurray JJ, Dunselman P, Wedel H, Cleland JG, Lindberg M, Hjalmarson A, Kjekshus J, Waagstein F, Apetrei E, Barrios V, Böhm M, Kamenský G, Komajda M, Mareev V, Wikstrand J; CORONA Study Group.

J Am Coll Cardiol. 2010 Oct 5;56(15):1196-204. doi: 10.1016/j.jacc.2010.02.075.

PMID:
20883926
[PubMed - indexed for MEDLINE]
Free Article
12.

Randomized dose-response study of rosuvastatin in Japanese patients with hypercholesterolemia.

Saito Y, Goto Y, Dane A, Strutt K, Raza A.

J Atheroscler Thromb. 2003;10(6):329-36.

PMID:
15037821
[PubMed - indexed for MEDLINE]
Free Article
13.

[Statin therapy for systolic heart failure. The CORONA trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)].

Angermann CE, Nitschmann S.

Internist (Berl). 2008 Jul;49(7):884-6. doi: 10.1007/s00108-008-2124-x. German. No abstract available.

PMID:
18427760
[PubMed - indexed for MEDLINE]
14.

Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide.

Wedel H, McMurray JJ, Lindberg M, Wikstrand J, Cleland JG, Cornel JH, Dunselman P, Hjalmarson A, Kjekshus J, Komajda M, Kuusi T, Vanhaecke J, Waagstein F; CORONA Study Group.

Eur J Heart Fail. 2009 Mar;11(3):281-91. doi: 10.1093/eurjhf/hfn046. Epub 2009 Jan 24.

PMID:
19168876
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).

Cleland JG, McMurray JJ, Kjekshus J, Cornel JH, Dunselman P, Fonseca C, Hjalmarson A, Korewicki J, Lindberg M, Ranjith N, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J; CORONA Study Group.

J Am Coll Cardiol. 2009 Nov 10;54(20):1850-9. doi: 10.1016/j.jacc.2009.06.041.

PMID:
19892235
[PubMed - indexed for MEDLINE]
Free Article
16.

Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.

Glueck CJ, Aregawi D, Agloria M, Khalil Q, Winiarska M, Munjal J, Gogineni S, Wang P.

Clin Ther. 2006 Jun;28(6):933-42.

PMID:
16860175
[PubMed - indexed for MEDLINE]
17.

Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study).

Ballantyne CM, Weiss R, Moccetti T, Vogt A, Eber B, Sosef F, Duffield E; EXPLORER Study Investigators.

Am J Cardiol. 2007 Mar 1;99(5):673-80. Epub 2007 Jan 4.

PMID:
17317370
[PubMed - indexed for MEDLINE]
18.

Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.

Albert MA, Glynn RJ, Fonseca FA, Lorenzatti AJ, Ferdinand KC, MacFadyen JG, Ridker PM.

Am Heart J. 2011 Jul;162(1):106-14.e2. doi: 10.1016/j.ahj.2011.03.032. Epub 2011 Jun 12.

PMID:
21742096
[PubMed - indexed for MEDLINE]
19.

Monday, Wednesday, and Friday dosing of rosuvastatin in patients previously intolerant to statin therapy.

Mackie BD, Satija S, Nell C, Miller J 3rd, Sperling LS.

Am J Cardiol. 2007 Jan 15;99(2):291. Epub 2006 Nov 27.

PMID:
17223437
[PubMed - indexed for MEDLINE]
20.

Usefulness of aggressive lipid-lowering therapy with rosuvastatin in hypercholesterolemic patients with concomitant type 2 diabetes.

Mori Y, Kuriyama G, Tanaka T, Tajima N.

Endocrine. 2009 Dec;36(3):412-8. doi: 10.1007/s12020-009-9235-6. Epub 2009 Oct 16. No abstract available.

PMID:
19834827
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk